Polymerase chain reaction

Polymerase chain reaction is a widely used laboratory technique in molecular biology developed by Kary Mullis at Cetus Corporation, which enables the amplification of specific DNA sequences, such as those found in Escherichia coli or Homo sapiens. This method has revolutionized the field of genetics and has been instrumental in the development of various fields, including forensic science, genetic engineering, and cancer research at institutions like Harvard University and Stanford University. The technique has been used by renowned scientists like James Watson and Francis Crick to study the structure of DNA and by Jennifer Doudna and Emmanuelle Charpentier to develop the CRISPR-Cas9 gene editing tool. Researchers at MIT and University of California, Berkeley have also utilized PCR to advance our understanding of gene expression and epigenetics.

Introduction

The polymerase chain reaction is a laboratory technique used to amplify specific DNA sequences, such as those found in bacteria like Staphylococcus aureus or viruses like HIV. This technique is widely used in various fields, including medicine at Johns Hopkins University and Mayo Clinic, biotechnology at Genentech and Amgen, and forensic science at the FBI and Scotland Yard. The PCR technique has been used by scientists like Rosalind Franklin and Maurice Wilkins to study the structure of DNA and by David Baltimore and Howard Temin to understand the mechanisms of gene regulation. Researchers at University of Oxford and University of Cambridge have also utilized PCR to investigate the genetic basis of diseases like sickle cell anemia and cystic fibrosis.

Principle

The principle of the polymerase chain reaction is based on the ability of DNA polymerase enzymes, such as Taq polymerase from Thermus aquaticus, to synthesize new DNA strands by adding nucleotides to a template strand. This process is facilitated by the use of primers, short DNA sequences that are complementary to the target sequence, such as those used in PCR-based diagnostics at Centers for Disease Control and Prevention and World Health Organization. The reaction is typically carried out in a thermal cycler, which allows for the rapid heating and cooling of the reaction mixture, enabling the denaturation of DNA and the annealing of primers to the target sequence. Scientists like Frederick Sanger and Walter Gilbert have developed methods for DNA sequencing using PCR and have been recognized with awards like the Nobel Prize in Chemistry.

Procedure

The procedure for the polymerase chain reaction typically involves several steps, including the preparation of the reaction mixture, which includes the DNA template, primers, dNTPs, and DNA polymerase, such as Pfu polymerase from Pyrococcus furiosus. The reaction mixture is then subjected to a series of thermal cycles, which typically include denaturation at high temperatures, annealing at lower temperatures, and extension at temperatures optimal for DNA synthesis. The reaction is often carried out in a PCR thermal cycler, such as those used at National Institutes of Health and European Molecular Biology Laboratory. Researchers at University of California, San Francisco and Duke University have developed PCR-based methods for gene expression analysis and mutation detection.

Applications

The polymerase chain reaction has a wide range of applications in various fields, including medicine at Cleveland Clinic and Massachusetts General Hospital, biotechnology at Biogen and Gilead Sciences, and forensic science at the Federal Bureau of Investigation and Interpol. The technique is used for the diagnosis of genetic disorders like sickle cell anemia and cystic fibrosis, as well as for the detection of infectious diseases like HIV and tuberculosis. Researchers at University of Chicago and Columbia University have also used PCR to study the genetic basis of complex diseases like cancer and neurodegenerative disorders. The technique has been used by scientists like Eric Lander and David Haussler to develop genomic approaches for disease diagnosis and personalized medicine.

History

The polymerase chain reaction was first developed in the 1980s by Kary Mullis at Cetus Corporation, who was awarded the Nobel Prize in Chemistry in 1993 for his discovery. The technique was initially met with skepticism, but it quickly gained acceptance and has since become a cornerstone of molecular biology research at institutions like California Institute of Technology and University of California, Los Angeles. The development of PCR has been influenced by the work of scientists like Alec Jeffreys and Mary-Claire King, who have used the technique to study genetic variation and gene expression. Researchers at University of Wisconsin–Madison and University of Texas at Austin have also contributed to the development of PCR-based methods for genetic analysis.

Variations

There are several variations of the polymerase chain reaction technique, including real-time PCR, which allows for the quantification of DNA sequences in real-time, and reverse transcription PCR, which enables the amplification of RNA sequences. Other variations include nested PCR, which involves the use of multiple sets of primers to increase specificity, and asymmetric PCR, which allows for the amplification of single-stranded DNA. Researchers at University of Illinois at Urbana–Champaign and Georgia Institute of Technology have developed PCR-based methods for gene editing and genome engineering. Scientists like George Church and David Liu have used PCR to develop synthetic biology approaches for biotechnology applications. Category: Laboratory techniques